News · 26 weeks42-60%
2026-04-192026-10-11
Mix2090d
- Insider9(45%)
- Other5(25%)
- Earnings3(15%)
- SEC Filings3(15%)
Latest news
25 items- PROrthoPediatrics Corp. to Report Third Quarter Financial Results on October 27, 2026WARSAW, Ind., Oct. 13, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its third quarter 2026 financial results on Tuesday, October 27, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, October 27, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be a
- PROrthoPediatrics Expands Its Lower Extremity Bracing Portfolio with the Launch of OPSB® Knee 'TractorFIXWARSAW, Ind., Oct. 07, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the expansion of its OrthoPediatrics Specialty Bracing ("OPSB") portfolio with a new product launch, the OPSB® Knee 'TractorFIX contracture management orthosis. Knee 'TractorFIX is a first-of-its-kind pediatric bracing solution intended to treat knee contractures, pre-existing or developing, in pediatric patients approximately 2 to 21 years of age who are undergoing tibial treatment with an external fixator. The brace connects directly to the external fixator to support contr
- PROrthoPediatrics Sponsors the 10th Pediatric Orthopedic Surgical Techniques CourseWARSAW, Ind., Oct. 01, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced it sponsored the 10th Pediatric Orthopedic Surgical Techniques (POST) Course, which brought together a record 39 participants from 23 institutions across 22 cities and three countries. OrthoPediatrics’ President & CEO, David Bailey, commented, "I want to thank the Armstrong Children’s Orthopedic Alliance for their dedication to advancing pediatric orthopedic education worldwide. As the primary and Platinum Sponsor, OrthoPediatrics’ support was instrumental in bringing the 10t
- PROrthoPediatrics Surpasses 1,000 PNP Tibia Nail ImplantationsWARSAW, Ind., Sept. 22, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the recent implantation of the 1,000th Tibia Nail using its latest Pediatric Nailing Platform (PNP). The PNP Tibia System was designed to bring a world-class, pediatric-focused nailing system to surgeons, enabling the use of rigid tibial nails in pediatric patients. OrthoPediatrics’ introduction of the 7mm cannulated rigid tibial nail, the only product of its size, enables surgeons to treat patients who have previously been untreatable with adult systems. In fact, nearly 20
- INSIDERLarge owner Squadron Capital Llc sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Pritzker Jennifer N. sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Pelizzon David R sold $6,352,773 worth of shares (302,369 units at $21.01) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Squadron Capital Llc sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Pritzker Jennifer N. sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Pelizzon David R sold $7,761,194 worth of shares (336,831 units at $23.04) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Pritzker Jennifer N. sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERLarge owner Squadron Capital Llc sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Pelizzon David R sold $943,302 worth of shares (38,300 units at $24.63) (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- PROrthoPediatrics Announces Full Commercial Launch of 3P™ Pediatric Plating Platform® Hip System Following More Than 350 Successful ImplantationsWARSAW, Ind., Aug. 25, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics) (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced the full commercial launch of its 3P™ Pediatric Plating Platform® Hip System. Following a highly successful limited launch period that resulted in over 350 surgical implantations, the system is now broadly available to pediatric orthopedic surgeons throughout the United States. The 3P Hip System is the first system within the Company's broader Pediatric Plating Platform portfolio and represents a significant advancement in trauma and deformity correction. "The response to the 3P Hip System du
- SECSEC Form 10-Q filed by OrthoPediatrics Corp.10-Q - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- SECOrthoPediatrics Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits8-K - ORTHOPEDIATRICS CORP (0001425450) (Filer)
- PROrthoPediatrics Corp. Reports Second Quarter 2026 Financial Results and Increases 2026 Financial GuidanceWARSAW, Ind., Aug. 04, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced its financial results for the second quarter ended June 30, 2026. Second Quarter 2026 and Business Highlights Helped a record of nearly 46,000 children in the second quarter of 2026Generated new record high total revenue of $70.5 million for the second quarter of 2026, up 15% from $61.1 million in the second quarter of 2025; domestic revenue increased 14% and international revenue increased 22% in the quarterGrew worldwide Trauma & Deformity revenue 26% in the second q
- PROrthoPediatrics to Participate in the Canaccord Genuity 46th Annual Growth ConferenceWARSAW, Ind., July 29, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that Dave Bailey, President & Chief Executive Officer, and Fred Hite, Chief Operating Officer, and Chief Financial Officer, are scheduled to participate in a fireside chat at the Canaccord Genuity 46th Annual Growth Conference, held in Boston, MA. Event: Canaccord Genuity 46th Annual Growth ConferenceFormat: Fireside ChatDate: Wednesday, August 12, 2026Time: 9:00 am ET An audio webcast of the discussion will be available online at the OrthoPediatrics’ investor relations webs
- PROrthoPediatrics Corp. to Report Second Quarter Financial Results on August 4, 2026WARSAW, Ind., July 21, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced that the Company is scheduled to release its second quarter 2026 financial results on Tuesday, August 4, 2026 after the market closes. OrthoPediatrics will host a conference call on Tuesday, August 4, 2026 at 4:30 p.m. ET to discuss the results. Investors interested in listening to the conference call may do so by accessing a live and archived webcast of the event at www.orthopediatrics.com, on the Investors page in the Events & Presentations section. The webcast will be avai
- SECAmendment: SEC Form SCHEDULE 13G/A filed by OrthoPediatrics Corp.SCHEDULE 13G/A - ORTHOPEDIATRICS CORP (0001425450) (Subject)
- PROrthoPediatrics Announces Distribution Agreement with OSSIO, Inc. to Provide Revolutionary Orthopedic Fixation Technology to U.S. Children’s Hospitals NationwideWARSAW, Ind., June 24, 2026 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. ("OrthoPediatrics" or the "Company") (NASDAQ:KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, today announced an exclusive distribution agreement with OSSIO, Inc. ("OSSIO") that brings U.S. children’s hospitals nationwide a bio-integrative, metal-free fixation technology ideally suited for treatment of fractures and deformities in pediatric patients. After performing their fixation function, OSSIOfiber® implants are gradually replaced by the patient’s newly formed bone during the natural healing process. This technological advance in material science decreases the need for hardware r
- INSIDERDirector Pelizzon David R was granted 11,436 shares, increasing direct ownership by 35% to 44,384 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Fischer Kelly Laine was granted 11,436 shares, increasing direct ownership by 263% to 15,781 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
- INSIDERDirector Ruf Harold was granted 11,436 shares, increasing direct ownership by 136% to 19,837 units (SEC Form 4)4 - ORTHOPEDIATRICS CORP (0001425450) (Issuer)
KIDS FAQ
7 questionsWhat does OrthoPediatrics Corp. do?
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica...Where does KIDS stock trade?
OrthoPediatrics Corp. (KIDS) is listed on NASDAQ.What sector and industry is KIDS in?
OrthoPediatrics Corp. operates in the Health Care sector, Medical/Dental Instruments industry.When did OrthoPediatrics Corp. go public?
OrthoPediatrics Corp. (KIDS) completed its IPO in 2017.What are analysts saying about KIDS?
OrthoPediatrics Corp. has had 8 recent analyst actions on file. The most recent action was from TD Cowen: Buy with a $2300.00 price target on 2026-01-27. Recent price targets range from $2300.00 to $3700.00.What companies are similar to KIDS?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), BDX (Becton Dickinson and Company), MDLN (Medline Inc.). Compare KIDS side-by-side with any of them on Quantisnow.How can I track KIDS on Quantisnow?
Quantisnow aggregates OrthoPediatrics Corp.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow KIDS to receive live email and push alerts on every new disclosure.